MedPath

Effect of Adjuvant Continuous Theta Burst Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder and comparison with Placebo magnetic stimulation.

Phase 3
Conditions
Health Condition 1: F42- Obsessive-compulsive disorder
Registration Number
CTRI/2020/06/025881
Lead Sponsor
Shri Guru Ram Rai Institute of Medical and Health Sciences and Shri Mahant Indresh Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosis of OCD, according to International Classification of Diseases â?? 10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research (ICD-10 DCR).

2. Moderate to severe illness. Baseline Y-BOCS Score > or equal to 24.

3. Age between 18-59 years.

4. Right handed, normotensive patients.

Exclusion Criteria

1. Neurological disorders such as epilepsy, organic brain damage or any neurological procedures.

2. Pacemakers or other metal parts in the body.

3. ECT in past 6 months.

4. Any co morbid psychosis (F20-F29), Bipolar disorder or substance use disorders except nicotine and caffeine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Yale Brown Obsessive Compulsive Scale (Y-BOCS)Timepoint: To be Measured at 0, 7 and 21 days of transcranial magnetic stimulation (3 Point Rating).
Secondary Outcome Measures
NameTimeMethod
Hamilton Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D) and Clinical Global Impression (CGI).Timepoint: To be Measured at 0, 7 and 21 days of transcranial magnetic stimulation (3 Point Rating).
© Copyright 2025. All Rights Reserved by MedPath